Scartozzi M - Search Results

1

Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients.

Scartozzi M, Giampieri R, Maccaroni E, Del Prete M, Faloppi L, Bianconi M, Galizia E, Loretelli C, Belvederesi L, Bittoni A, Cascinu S. Scartozzi M, et al. Br J Cancer. 2012 Feb 28;106(5):799-804. doi: 10.1038/bjc.2012.17. Epub 2012 Feb 7. Br J Cancer. 2012. PMID: 22315053 Free PMC article.

2

Liver metastases from colorectal cancer.

Cascinu S, Catalano V, Scartozzi M, Baldelli AM, Cellerino R. Cascinu S, et al. Among authors: scartozzi m. Ann Oncol. 1997 Apr;8(4):393-9. doi: 10.1023/a:1008232421790. Ann Oncol. 1997. PMID: 9209671 Free article. No abstract available.

3

Locoregional treatments of unresectable liver metastases from colorectal cancer.

Cascinu S, Catalano V, Baldelli AM, Scartozzi M, Battelli N, Graziano F, Cellerino R. Cascinu S, et al. Among authors: scartozzi m. Cancer Treat Rev. 1998 Feb;24(1):3-14. doi: 10.1016/s0305-7372(98)90067-6. Cancer Treat Rev. 1998. PMID: 9606364 Review. No abstract available.

4

Mutations of hMLH1 and hMSH2 in patients with suspected hereditary nonpolyposis colorectal cancer: correlation with microsatellite instability and abnormalities of mismatch repair protein expression.

Scartozzi M, Bianchi F, Rosati S, Galizia E, Antolini A, Loretelli C, Piga A, Bearzi I, Cellerino R, Porfiri E. Scartozzi M, et al. J Clin Oncol. 2002 Mar 1;20(5):1203-8. doi: 10.1200/JCO.2002.20.5.1203. J Clin Oncol. 2002. PMID: 11870161

5

Loss of hMLH1 expression correlates with improved survival in stage III-IV ovarian cancer patients.

Scartozzi M, De Nictolis M, Galizia E, Carassai P, Bianchi F, Berardi R, Gesuita R, Piga A, Cellerino R, Porfiri E. Scartozzi M, et al. Eur J Cancer. 2003 May;39(8):1144-9. doi: 10.1016/s0959-8049(03)00197-7. Eur J Cancer. 2003. PMID: 12736115

6

Adjuvant chemotherapy in gastric cancer. The Italian experience and review of the literature.

Berardi R, Scartozzi M, Galizia E, Cascinu S. Berardi R, et al. Among authors: scartozzi m. Suppl Tumori. 2003 Sep-Oct;2(5):S45-7. Suppl Tumori. 2003. PMID: 12914390 Review.

7

Gastric cancer treatment: a systematic review.

Berardi R, Scartozzi M, Romagnoli E, Antognoli S, Cascinu S. Berardi R, et al. Among authors: scartozzi m. Oncol Rep. 2004 Apr;11(4):911-6. Oncol Rep. 2004. PMID: 15010894 Review.

8

[Non-small cell lung carcinoma: pathology, biology and prognosis].

Freddari F, Berardi R, Scartozzi M, Cascinu S. Freddari F, et al. Among authors: scartozzi m. Suppl Tumori. 2004 Mar-Apr;3(2):S3-4. Suppl Tumori. 2004. PMID: 15067954 Italian. No abstract available.

9

High curative resection rate with weekly cisplatin, 5-fluorouracil, epidoxorubicin, 6S-leucovorin, glutathione, and filgastrim in patients with locally advanced, unresectable gastric cancer: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD).

Cascinu S, Scartozzi M, Labianca R, Catalano V, Silva RR, Barni S, Zaniboni A, D'Angelo A, Salvagni S, Martignoni G, Beretta GD, Graziano F, Berardi R, Franciosi V; Italian Group for the Study of Digestive Tract Cancer (GISCAD). Cascinu S, et al. Among authors: scartozzi m. Br J Cancer. 2004 Apr 19;90(8):1521-5. doi: 10.1038/sj.bjc.6601752. Br J Cancer. 2004. PMID: 15083179 Free PMC article. Clinical Trial.

10

Molecular biology of sporadic gastric cancer: prognostic indicators and novel therapeutic approaches.

Scartozzi M, Galizia E, Freddari F, Berardi R, Cellerino R, Cascinu S. Scartozzi M, et al. Cancer Treat Rev. 2004 Aug;30(5):451-9. doi: 10.1016/j.ctrv.2004.01.001. Cancer Treat Rev. 2004. PMID: 15245777 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

373 results

Search Page

Filters